ResMed Inc (NYSE:RMD)
$ 234.42 1.84 (0.79%) Market Cap: 34.14 Bil Enterprise Value: 34.57 Bil PE Ratio: 30.81 PB Ratio: 6.57 GF Score: 99/100

Q1 2023 Resmed Inc Earnings Call Transcript

Oct 27, 2022 / 08:30PM GMT
Release Date Price: $232.29 (-0.72%)
Operator

Hello, and welcome to the ResMed First Quarter Fiscal 2023 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to your host, Amy Wakeham, Vice President, Investor Relations and Corporate Communications. Please go ahead, Amy.

Amy Wakeham
ResMed Inc. - VP of IR & Corporate Communications

Great. Thank you, Kevin. Hi, everyone, and thanks for joining us. This call is being webcast live and the replay will be available on the Investor Relations section of our corporate website later today, along with a copy of their earnings press release and presentation, which are both available now.

Joining me on the call today are Chief Executive Officer, Mick Farrell; and Chief Financial Officer, Brett Sandercock. Mick will provide a brief high-level overview of our financial results. He'll review progress towards our ResMed 2025 strategic goals and discuss the current state of things as we continue to navigate the ongoing macro industry and supply chain challenges. Brett

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot